Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Patterson

Showing results (531-540 of 599) with videos related to

Pageof 60
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapyJohan Maertens, Issam Raad, George Petrikkos, et al.
Eukaryotic Cell|July 13, 2006
Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatusWilliam J Steinbach, Robert A Cramer, B Zachary Perfect, et al.
Eukaryotic Cell|June 8, 2006
Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin productionRobert A Cramer, Michael P Gamcsik, Rhea M Brooking, et al.
Journal of Fungi (Basel, Switzerland)|September 27, 2023
High-Throughput Screening of the Repurposing Hub Library to Identify Drugs with Novel Inhibitory Activity against <i>Candida albicans</i> and <i>Candida auris</i> BiofilmsOlabayo H Ajetunmobi, Gina Wall, Bruna Vidal Bonifacio, et al.
Genomics|June 15, 1999
Molecular basis of feline beta-glucuronidase deficiency: an animal model of mucopolysaccharidosis VIIJ C Fyfe, R L Kurzhals, M E Lassaline, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2016
The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattiiShawn R Lockhart, Annette W Fothergill, Naureen Iqbal, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancerMarta C Dahiya, Spencer W Redding, Rajiv S Dahiya, et al.
The Journal of Infection|May 9, 2006
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosisDavid W Denning, Kieren A Marr, Wendi M Lau, et al.
Open Forum Infectious Diseases|December 8, 2021
Coronavirus Disease 2019-Associated Invasive Fungal InfectionJohn W Baddley, George R Thompson, Sharon C-A Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40Mitchell Goldman, Gretchen A Cloud, Karen D Wade, et al.
Pageof 60

Showing results (531-540 of 599) with videos related to

Sort By:
Pageof 60
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapyJohan Maertens, Issam Raad, George Petrikkos, et al.
Eukaryotic Cell|July 13, 2006
Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatusWilliam J Steinbach, Robert A Cramer, B Zachary Perfect, et al.
Eukaryotic Cell|June 8, 2006
Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin productionRobert A Cramer, Michael P Gamcsik, Rhea M Brooking, et al.
Journal of Fungi (Basel, Switzerland)|September 27, 2023
High-Throughput Screening of the Repurposing Hub Library to Identify Drugs with Novel Inhibitory Activity against <i>Candida albicans</i> and <i>Candida auris</i> BiofilmsOlabayo H Ajetunmobi, Gina Wall, Bruna Vidal Bonifacio, et al.
Genomics|June 15, 1999
Molecular basis of feline beta-glucuronidase deficiency: an animal model of mucopolysaccharidosis VIIJ C Fyfe, R L Kurzhals, M E Lassaline, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2016
The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattiiShawn R Lockhart, Annette W Fothergill, Naureen Iqbal, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancerMarta C Dahiya, Spencer W Redding, Rajiv S Dahiya, et al.
The Journal of Infection|May 9, 2006
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosisDavid W Denning, Kieren A Marr, Wendi M Lau, et al.
Open Forum Infectious Diseases|December 8, 2021
Coronavirus Disease 2019-Associated Invasive Fungal InfectionJohn W Baddley, George R Thompson, Sharon C-A Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40Mitchell Goldman, Gretchen A Cloud, Karen D Wade, et al.
Pageof 60